key: cord-0079073-10igrcef authors: León-Figueroa, Darwin A.; Bonilla-Aldana, D. Katterine; Pachar, Monica; Romaní, Luccio; Saldaña-Cumpa, Hortencia M.; Anchay-Zuloeta, Claudia; Diaz-Torres, Milagros; Franco-Paredes, Carlos; Suárez, José Antonio; Ramirez, Juan David; Paniz-Mondolfi, Alberto; Rodriguez-Morales, Alfonso J. title: The never ending global emergence of viral zoonoses after COVID-19? The rising concern of monkeypox in Europe, North America and beyond date: 2022-05-26 journal: Travel Med Infect Dis DOI: 10.1016/j.tmaid.2022.102362 sha: 24ddb573e7202000b35843da21cb4d7848456aba doc_id: 79073 cord_uid: 10igrcef nan Since its emergence in early 2020 and up until the end of May 2022, the coronavirus SARS-CoV-2 has 31 caused more than 524 million COVID-19 cases globally, with 6.2 million deaths (~1.2%, case fatality rate, 32 CFR) [1, 2] . Today, the risk for concurrent pandemics or the onset of future pandemics is inevitable. In fact, 33 the history of mankind has been shaped by infectious diseases acting as independent forces of societal 34 transformation. Zoonotic viruses represent the greatest threat impacting global health, including not only 35 coronaviruses like the Middle East Respiratory Syndrome (MERS-CoV) [3] but also haemorrhagic fever 36 viruses, hantaviruses, arenaviruses, arboviruses [4] , and zoonotic influenza viruses [5] [6] [7] [8] . In addition, re-37 emerging conditions are also a cause of concern, particularly those comprising multiple zoonotic viruses 38 originating from both Africa and Asia. 39 Amid the COVID-19 pandemic, the increasing reporting of cases of monkeypox virus infection in humans 40 spreading through many countries outside Africa is a major reason for concern [5-12]. reported monkeypox (Figure 1 ). In North America, Canada and United States of America, have confirmed 104 cases. Beyond Europe, Israel and Australia have also notified suspected and confirmed cases, with a 105 suspected case in Argentina (Figure 1) , for a total of 245 cases, 160 of them confirmed (65%). 106 The classic mode of transmission of this infection relies on exposure to live or dead animals through hunting 107 or handling bush meat. The animal reservoir of the monkeypox virus is unknown; however, there is 108 evidence that places native African rodents as a potential source, which may explain the spread of the 109 disease outside this continent. Since the first reported case in Zaire in 1970, 95% of the informed cases to 110 date are from the DRC. Since the 2000s, there has been an increased number of Monkeypox cases 111 throughout the New World and outbreaks associated with contact with African rodents sold as pets. One of 112 the factors related to the gradual increase in cases is the cessation of routine vaccination against Smallpox, 113 which was mandatory until 1972 and ceased after its eradication in 1980 [32] . An interesting aspect about 114 the current outbreak relates to the fact that disease clusters are known to include high risk groups like men 115 who have sex with men (MSM). This is important from a disease dynamics standpoint for several reasons: 116 1. it could explain why despite the relatively inefficient transmission of monkeypox, so many cases are 117 being reported in such a broad geographical extension. 2. Provides evidence on close contact as the potential 118 source of transmission and 3. Argue in favour of a possible sexual link for all these seemingly unconnected 119 outbreaks throughout MSM communities. Naturally, its differential diagnosis would be challenging, 120 including other exanthematic febrile diseases, including Smallpox, Measles, Chickenpox, and Syphilis, 121 depending on the local epidemiology (e.g. Peruvian warts in some Latin American countries, or Buruli ulcer 122 in Africa) [33] . 123 Predicting the ongoing spread of Monkeypox to other geographic settings is challenging. Monkeypox is a 124 significant health concern for people living in endemic regions across Africa where virus circulation is 125 confirmed. However, it is also a global health security issue, and appropriate and effective interventions 126 prophylaxis for high-risk contacts within 4 days and up to 14 days of contact, but if given between 4-14 139 days after date of exposure, vaccination may reduce the symptoms of disease, but not prevent the disease 140 [36]. In addition to smallpox vaccine, immune globulin is available and can be used as prophylaxis for 141 severely immunocompromised patients, although the benefit still remains unclear [37] . Antiviral drugs 142 approved to treat smallpox including tecovirimat and brincidofovir, can be potentially deployed for its use 143 on treating monkeypox [38] . J o u r n a l P r e -p r o o f Clinical, laboratory and imaging features of COVID-19: A systematic review and 162 meta-analysis 2017-18: a clinical and epidemiological report Genomic history 193 of human monkey pox infections in the Central African Republic between Emergence of human Monkeypox in west Africa Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, 202 and Evolution Outbreaks of monkeypox and 205 serological surveys in nonhuman primates Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in 208 Transmission dynamics of Monkeypox virus: 210 a mathematical modelling approach The Evolving Epidemiology of Human Monkeypox: Questions Still to Be Answered Fatal monkeypox in wild-living sooty mangabey Factors affecting the likelihood of Monkeypox's emergence and spread in 218 the post-smallpox era The current status of human Monkeypox: memorandum from a WHO meeting Isolation of monkeypox virus from wild squirrel infected in nature Monkeypox virus: ecology and public health significance Outbreak of human Monkeypox The changing epidemiology of human 231 monkeypox-A potential threat? A systematic review Importance of epidemiological research of Monkeypox: is 234 incidence increasing? Modelling human-to-human transmission of Monkeypox Viruela del mono en España | Ascienden a 23 los casos de viruela no humana confirmados en España | Salud Reemergence of Monkeypox: prevalence, diagnostics, and 244 countermeasures Dermatological conditions in international 247 pediatric travelers: epidemiology, prevention and management Bats in ecosystems and their Wide spectrum of viral infectious potential threats CoV-2 and other emerging viruses Human monkeypox: an emerging zoonosis Human Monkeypox: Current State of Knowledge and Implications for the Future Med Infect Dis Pharmacokinetics and Efficacy 263 of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model